Absence or impairment in ADA-1 is additionally associated with the development of severe combined immunodeficiency (SCID) in humans, where no T, B or NK cells are present [59,62], but also non-immunologic manifestations including liver, skeletal, cognitive and behavioral abnormalities are observed [59]. This evidence concerns the gene ADA and severe combined immunodeficiency.